# Effect GnRH Agonist Administration in Endometriosis Cyst Patients

> **NCT06525155** · PHASE3 · RECRUITING · sponsor: **Rumah Sakit Pusat Angkatan Darat Gatot Soebroto** · enrollment: 32 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Triptorelin Embonate
- **DRUG:** Triptorelin Embonate

## Key facts

- **NCT ID:** NCT06525155
- **Lead sponsor:** Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06525155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06525155, "Effect GnRH Agonist Administration in Endometriosis Cyst Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06525155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*